2004
DOI: 10.1016/j.addr.2004.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Micro and nano-fabrication of biodegradable polymers for drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
171
0
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 296 publications
(174 citation statements)
references
References 42 publications
0
171
0
3
Order By: Relevance
“…The fabrication of advanced drug delivery systems (DDSs) is increasingly 72 dependent on the creation of complex architectures and understanding 73 structure-activity relationships at the nanoscale [1][2][3]. To this end, core-shell 74 nanostructures have been very widely studied in the production of functional 75 nanomaterials, including those for biomedical applications [4][5][6].…”
Section: Introduction 71mentioning
confidence: 99%
“…The fabrication of advanced drug delivery systems (DDSs) is increasingly 72 dependent on the creation of complex architectures and understanding 73 structure-activity relationships at the nanoscale [1][2][3]. To this end, core-shell 74 nanostructures have been very widely studied in the production of functional 75 nanomaterials, including those for biomedical applications [4][5][6].…”
Section: Introduction 71mentioning
confidence: 99%
“…In addition, dextran possesses multiple hydroxyls which are convenient for chemical modification to endow polymersome surfaces with various desired functions such as drug-targeting and diagnostic recognition. In addition, poly(ε-caprolactone) (PCL) was chosen as the hydrophobic block of the amphiphilic copolymer for its well demonstrated biocompatibility, biodegradability, and wide utilization as a drug delivery material [24,25]. However, there are limited studies regarding block copolymers with dextran as hydrophilic segment so far.…”
Section: Introductionmentioning
confidence: 99%
“…Both polymers have been approved by FDA for drug delivery (Jain et al, 1998;Södergård and Stolt, 2002;Panyam and Labhasetwar, 2003) and widely used as excipients in nanoprecipitation processes (Jain, 2000;Lu and Chen, 2004). The main objectives of this study were: (i) to make appropriate choice of good and poor solvent of the polymers, (ii) to observe the mixing process in situ using a microscope video system, and (iii) to investigate the effect of operating parameters, system geometry, and surfactants on the final particle size distribution.…”
Section: Introductionmentioning
confidence: 99%